TR
Traws Pharma, Inc.
TRAW · NASDAQ
$0.59 +11.34% (+$0.06)
1M -5.95%
Market Cap $8.09M
P/E Ratio 0.88x
Div. Yield -
ROE -
Bulios Fair Price
$0.76
29.6% upside
Trenutna cena
$0.59
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TRAW trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
87 /100
Cheap P/S 2.90x
P/E 0.88x
P/FFO N/A
Growth
100 /100
Growing Rev. growth 131.12%
FCF growth N/A
Book val. growth N/A
Profitability
40 /100
Moderate Net margin 328.67%
Op. margin 640.68%
FCF margin 744.44%
Quality
83 /100
Excellent ROA 86.37%
Asset turnover 0.26x
ROIC 3,379.02%
Debt
20 /100
High Current ratio 0.72x
Int. coverage N/A
Net debt/EBITDA N/A
Stability
9 /100
Unstable Rev. volatility 655.01%
EPS volatility 80.25%
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TRAW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Iain D. Dukes
Employees
7
Headquarters
Newtown
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report